September 9, 2025- ZOLL® introduced that transvenous phrenic nerve stimulation (TPNs)- the therapy that’s presently solely obtainable by the Zoll brakeEDē® System – is now included within the up to date pointers of the American Academy or Sleep Medication (Aasmic) for the therapy of Central Sleep Apnea (CSA).

The bait acknowledges the advantages of the affected person of TPNs, which emphasizes the enhancements in central occasion indices, oxygen designing index, high quality of life and numerous sleep structure measures. TPNS is really useful each in major central sleep apnea and central sleep apnea as a consequence of coronary heart failure.

TPNS is the one new remedy that has been added to the rules because the final replace in 2012. The AASM famous the event of TPNs and extra details about adaptive servo air flow (ASV) as the first drivers behind the up to date pointers. TPNS can be one in all solely two therapies really useful by Directive to indicate improved scientific ends in the severity of the illness, extreme sleepiness and cardiovascular well being.

Learn extra